MOLECULAR CRO
DEAD

Serial Number

79115016

Owner

Comprehensive Biomarker Center GmbH

Filing Date

Feb 10, 2012

Add to watchlist:

No watchlists yet
View on USPTO

MOLECULAR CRO Trademark

Serial Number: 79115016

MOLECULAR CRO is a trademark filed by Comprehensive Biomarker Center GmbH on February 10, 2012. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Comprehensive Biomarker Center GmbH (2 trademarks)

In Neuenheimer Feld 583

Entity Type: 98

febit holding gmbh (5 trademarks)

Im Neuenheimer Feld 519
Heidelberg , DE

Entity Type: 99

Trademark Details

Filing Date

February 10, 2012

Registration Date

Not Registered

Goods & Services

professional business consultation and business organization consultation in the market authorization of medicines and medical devices; planning and conducting of trade fairs for economic or advertising purposes; import-export agencies in the field of medicines and medical devices; wholesale store services and retail store services featuring medicines; business marketing services related to medicines and medical devices; commercial information and advice for consumers; wholesale store services in the chemical products sector; market reports and studies

medical services; veterinary services; hygienic and beauty care; medical diagnostic testing, monitoring and reporting services in preclinical and clinical settings; veterinary specialty services providing advanced medical and diagnostic services for animals; medical services, namely, medical and clinical examinations

scientific and technological services, namely, scientific research, analysis and testing in the field of medicine, genetics and medical biomarkers; testing, analysis, and evaluation of medical diagnostic and biomarker preparations to assure compliance with industry standards; industrial chemical, biochemical, biological and bacteriological research and analysis; medical and scientific research information in the field of medicine, genetics and medical biomarkers; research and development of vaccines and medicines; design and testing for new product development, namely, pharmaceutical and diagnostic preparations and substances; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; testing, analyzing and evaluating new medicines; chemical research laboratories, pharmaceutical research laboratories, medical research laboratories, bacteriology research laboratories, molecular biological/biological research laboratories; medical and scientific research, namely, conducting clinical trials for others; scientific analyses in the field of chemistry, biology, molecular biology, pharmaceutics, and food technology; computer development of software in the field of the operation of therapeutic and diagnostic equipment and for the data processing for the purpose of imaging; scientific and technological services, namely, scientific research particular in the field of chemistry, genetics, biology, bioengineering, and biochemistry; chemical, biochemical, biological and bacteriological research and analysis; DNA and RNA analysis services, namely, development and research of DNA, RNA and scientific research in the field of biochemistry and biotechnology; scientific research; preparation of scientific opinions in the field of scientific research and development; advisory services relating to biotechnology, pharmaceutical research and development and genetic science; medical and scientific research, namely, the extraction or cultivation, scientific processing, and scientific analysis of biomaterials and compiling data for research purposes in the filed of medical science and medical consultancy; contract research in the field of pharmacological and clinical development of medicines; scientific data analysis for scientific and technical purposes, namely analysis of data originating from clinical trials; scientific laboratory services, namely, scientific development, research, identification, validation, analysis and interpretation of biomarkers, particularly nucleic acid based biomarkers

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sep 4, 2022 DENA
DEATH OF INTERNATIONAL REGISTRATION
Sep 3, 2022 DETH
NEW REPRESENTATIVE AT IB RECEIVED
Jun 9, 2016 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 23, 2014 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Oct 7, 2014 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 7, 2014 FICR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 8, 2014 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Apr 24, 2014 CRCV
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 24, 2014 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 8, 2014 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 8, 2014 OPNR
CHANGE OF OWNER RECEIVED FROM IB
Dec 23, 2013 CHLD
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 7, 2013 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 7, 2013 ABN2
FINAL REFUSAL MAILED
Feb 22, 2013 CNFR
FINAL REFUSAL WRITTEN
Feb 22, 2013 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2013 TROA
REFUSAL PROCESSED BY IB
Aug 30, 2012 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 9, 2012 RFCS
REFUSAL PROCESSED BY MPU
Aug 9, 2012 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 9, 2012 RFCR
NON-FINAL ACTION WRITTEN
Aug 8, 2012 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 7, 2012 MAFR
ASSIGNED TO EXAMINER
Aug 3, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 3, 2012 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 2, 2012 REPR